Page last updated: 2024-09-05

organophosphonates and Insulin Resistance

organophosphonates has been researched along with Insulin Resistance in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (33.33)29.6817
2010's4 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ecelbarger, CM; Kumari, M; Mishra, P; Pandey, G; Sharma, R; Tiwari, S1
Arnett, DK; Bagchi, S; Chi, BH; Heimburger, DC; Kabagambe, EK; Kiage, JN; Koethe, JR; Nyirenda, CK; Wellons, MF1
Jackson, AG; Moyle, GJ; Randell, PA; Yale, K; Zhong, L1
Back, DJ; Boffito, M; Jackson, AG; Mandalia, S; Moyle, GJ; Randell, PA; Taylor, J; Tjia, JF1
Liu, G1
Carr, A; Chuah, J; Cooper, DA; Doong, N; French, M; Hoy, J; Hudson, J; Law, M; Mallal, S; Smith, D1

Reviews

1 review(s) available for organophosphonates and Insulin Resistance

ArticleYear
Protein tyrosine phosphatase 1B inhibition: opportunities and challenges.
    Current medicinal chemistry, 2003, Volume: 10, Issue:15

    Topics: Acetates; Animals; Benzoates; Enzyme Inhibitors; Humans; Hydroquinones; Insulin Resistance; Molecular Mimicry; Oligonucleotides, Antisense; Organophosphonates; Phosphotyrosine; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Protein Tyrosine Phosphatases; Salicylates; Structure-Activity Relationship

2003

Trials

3 trial(s) available for organophosphonates and Insulin Resistance

ArticleYear
The effect of tenofovir disoproxil fumarate on whole-body insulin sensitivity, lipids and adipokines in healthy volunteers.
    Antiviral therapy, 2010, Volume: 15, Issue:2

    Topics: Adenine; Adipokines; Adult; Anti-HIV Agents; Cholesterol; Cholesterol, LDL; Cross-Over Studies; Drug Administration Schedule; Glucose Clamp Technique; HIV Seronegativity; Humans; Insulin; Insulin Resistance; Lipid Metabolism; Male; Organophosphonates; Reverse Transcriptase Inhibitors; Tenofovir; Treatment Outcome; Young Adult

2010
Effect of boosted fosamprenavir or lopinavir-based combinations on whole-body insulin sensitivity and lipids in treatment-naive HIV-type-1-positive men.
    Antiviral therapy, 2010, Volume: 15, Issue:8

    Topics: Adenine; Adipose Tissue; Adult; Anti-HIV Agents; Blood Glucose; Carbamates; Confidence Intervals; Drug Administration Schedule; Drug Combinations; Dyslipidemias; Furans; HIV Infections; HIV-1; Humans; Insulin; Insulin Resistance; Lamivudine; Lipids; Lopinavir; Male; Organophosphates; Organophosphonates; Pyrimidinones; Ritonavir; Sulfonamides; Tenofovir

2010
HIV protease inhibitor substitution in patients with lipodystrophy: a randomized, controlled, open-label, multicentre study.
    AIDS (London, England), 2001, Sep-28, Volume: 15, Issue:14

    Topics: Adenine; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Body Composition; Carnitine; Dideoxynucleosides; Drug Administration Schedule; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Hydroxyurea; Insulin Resistance; Lipodystrophy; Male; Middle Aged; Nevirapine; Organophosphonates; Quality of Life; Reverse Transcriptase Inhibitors; RNA, Viral; Treatment Outcome

2001

Other Studies

2 other study(ies) available for organophosphonates and Insulin Resistance

ArticleYear
Deletion of insulin receptor in the proximal tubule and fasting augment albumin excretion.
    Journal of cellular biochemistry, 2019, Volume: 120, Issue:6

    Topics: Albuminuria; Animals; Creatinine; Epithelial Cells; Fasting; Fluorescein-5-isothiocyanate; Gene Expression Regulation; Glucose; Glucose Tolerance Test; Humans; Insulin; Insulin Resistance; Kidney Tubules, Proximal; Low Density Lipoprotein Receptor-Related Protein-2; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Naphthalenes; Organophosphonates; Primary Cell Culture; Receptor, Insulin; Receptors, Cell Surface; Serum Albumin

2019
Cardiometabolic risk factors among HIV patients on antiretroviral therapy.
    Lipids in health and disease, 2013, Apr-10, Volume: 12

    Topics: Adenine; Adolescent; Adult; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Cardiovascular Diseases; Cholesterol, HDL; Cholesterol, LDL; Cyclopropanes; Female; HIV; HIV Infections; Humans; Insulin Resistance; Lamivudine; Male; Middle Aged; Nevirapine; Organophosphonates; Risk Factors; Stavudine; Tenofovir; Triglycerides; Zambia; Zidovudine

2013